0000899243-19-028704.txt : 20191206
0000899243-19-028704.hdr.sgml : 20191206
20191206172258
ACCESSION NUMBER: 0000899243-19-028704
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191206
FILED AS OF DATE: 20191206
DATE AS OF CHANGE: 20191206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schor Chen
CENTRAL INDEX KEY: 0001340875
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 191273854
MAIL ADDRESS:
STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC.
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: resTORbio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-06
0
0001720580
resTORbio, Inc.
TORC
0001340875
Schor Chen
C/O RESTORBIO, INC.
500 BOYLSTON STREET, 13TH FLOOR
BOSTON
MA
02116
1
1
0
0
President and CEO
Common Stock
2019-12-06
4
A
0
344000
0.00
A
669000
D
Common Stock
1567363
I
See Footnote
Stock Option (Right to Buy)
1.27
2019-12-06
4
A
0
258000
0.00
A
2029-12-05
Common Stock
258000
258000
D
The Reporting Person was issued Restricted Stock Units ("RSU"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
Represents 599,363 shares held directly by an irrevocable family trust having an independent trustee, 25,000 shares held by a revocable family trust of which the Reporting Person is the trustee, 643,000 shares held directly by an irrevocable family trust having an independent trustee, 25,000 shares held directly by a revocable trust of which the spouse is the trustee and 275,000 shares held directly by a grantor retained annuity trust of the spouse.
25% of the shares shall vest on December 6, 2020, with the remainder vesting in 36 equal monthly installments thereafter.
/s/ Chen Schor
2019-12-06